| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | EX-527 | CTRPv2 | pan-cancer | AAC | -0.073 | 0.06 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.053 | 0.06 |
| mRNA | AG-014699 | GDSC1000 | pan-cancer | AAC | -0.07 | 0.06 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.072 | 0.06 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.07 |
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.067 | 0.07 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.065 | 0.07 |
| mRNA | SB 216763 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.07 |
| mRNA | Cyclopamine | GDSC1000 | pan-cancer | AAC | 0.11 | 0.07 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.08 |